CRIPPA, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.242
EU - Europa 1.936
AS - Asia 631
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
OC - Oceania 3
Totale 4.825
Nazione #
US - Stati Uniti d'America 2.235
GB - Regno Unito 1.024
CN - Cina 517
SE - Svezia 177
IE - Irlanda 159
DE - Germania 144
FI - Finlandia 137
FR - Francia 132
IT - Italia 83
SG - Singapore 55
UA - Ucraina 38
TR - Turchia 20
BE - Belgio 15
JP - Giappone 11
KR - Corea 9
CA - Canada 7
CZ - Repubblica Ceca 7
IR - Iran 7
RU - Federazione Russa 6
NL - Olanda 4
RO - Romania 4
AU - Australia 3
CL - Cile 3
EU - Europa 3
IL - Israele 3
BG - Bulgaria 2
IN - India 2
MA - Marocco 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BF - Burkina Faso 1
BO - Bolivia 1
BR - Brasile 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
Totale 4.825
Città #
Southend 956
Jacksonville 414
Chandler 393
Woodbridge 292
Ann Arbor 233
Dublin 159
Houston 146
Ashburn 108
Wilmington 74
Beijing 72
Lawrence 64
Princeton 64
Jinan 55
Nanjing 47
Shenyang 45
Hebei 39
Singapore 38
Sindelfingen 35
New York 29
Tianjin 29
Haikou 27
Helsinki 25
Lancaster 21
Ningbo 18
Zhengzhou 18
Nanchang 17
Verona 17
Brussels 15
Milan 15
Taiyuan 15
Taizhou 14
Seattle 13
Changsha 12
Jiaxing 12
Hangzhou 11
Boardman 10
Falls Church 10
Grafing 10
Lanzhou 10
Tokyo 10
Guangzhou 9
Los Angeles 9
Norwalk 9
Seoul 9
Auburn Hills 6
Düsseldorf 6
Dearborn 5
Fairfield 5
Washington 5
Cagliari 4
Fuzhou 4
San Francisco 4
Toronto 4
Brno 3
Chicago 3
Kent 3
Redmond 3
Redwood City 3
Rome 3
Bussolengo 2
Campbell 2
Dongguan 2
Henderson 2
Ivrea 2
Jeffries 2
London 2
Melbourne 2
Montréal 2
Nesso 2
Nürnberg 2
San Mateo 2
Sofia 2
Tappahannock 2
Torino 2
Xiangfen 2
Yicheng 2
Zanjan 2
Amsterdam 1
Angri 1
Atlanta 1
Augusta 1
Bend 1
Boston 1
Boulder 1
Bucharest 1
Cambridge 1
Cantù 1
Changle 1
Chengdu 1
Clearwater 1
Croydon 1
Falkenstein 1
Forest City 1
Forlì 1
Frankfurt am Main 1
Groningen 1
Halifax 1
Hefei 1
Herbstein 1
Hertford 1
Totale 3.748
Nome #
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 129
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 127
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 110
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 106
Acute pancreatitis at the beginning of the 21st century: the state of the art. 101
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 101
Enucleation of pancreatic neoplasms. 101
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 96
Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. 96
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 94
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 94
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 93
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 92
Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. 91
The role of laparoscopy in advanced pancreatic cancer diagnosis. 90
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 89
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 88
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 88
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 86
Anastomotic leakage in pancreatic surgery. 86
Middle pancreatectomy: indications, short- and long-term operative outcomes. 86
Parenchyma-sparing resections for pancreatic neoplasms. 85
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 85
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 85
Anastomotic leakage in pancreatic surgery. 83
Anastomotic leakage in pancreatic surgery. 82
Enucleation of pancreatic neoplasms 80
Pancreatoblastoma in adults: a review of the literature. 80
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 79
Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results. 79
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 78
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. 77
Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. 75
Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus. 75
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 73
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 73
Early Versus Late Drain Removal After Standard Pancreatic Resections Results of a Prospective Randomized Trial 73
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 72
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection 69
Contrast-Enhanced Ultrasonography of the Pancreas 67
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 65
Improving cytological diagnosis of pancreatic cysts: Is it clinically necessary or just the latest fashion? 63
Extent of surgical resections for intraductal papillary mucinous neoplasms. 63
Rectal indomethacin to prevent post-ERCP pancreatitis. 63
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 63
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio 61
Surgical strategy in the treatment of pancreatic neuroendocrine tumors 60
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 60
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 59
Pancreatic cystic tumours: when to resect, when to observe 57
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 57
Pancreatic insufficiency after different resections for benign tumours. 56
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters 54
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 54
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 54
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 53
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 51
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms 47
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection 44
Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife? 43
Laparoscopic ileocecal resection for bowel endometriosis. 34
Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms 34
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 27
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 26
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age 25
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 21
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 18
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 18
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 11
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 9
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 6
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 4
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 4
Totale 4.878
Categoria #
all - tutte 15.747
article - articoli 14.752
book - libri 0
conference - conferenze 771
curatela - curatele 0
other - altro 224
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020538 75 17 2 53 55 48 70 65 17 59 26 51
2020/2021662 95 86 38 122 100 50 7 43 43 8 51 19
2021/2022476 51 116 4 30 14 20 15 29 21 9 57 110
2022/20231.051 80 121 103 151 89 244 27 92 108 6 24 6
2023/2024534 19 59 53 70 57 81 23 31 9 27 77 28
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 4.878